Ebola 2026 Update: American Patient Flown to Germany, 906 Suspected Cases — US Reroutes Flights from DRC

No. WHO declared the 2026 Ebola outbreak a Public Health Emergency of International Concern (PHEIC) on 17 May 2026 — but explicitly stated it does not meet the criteria of a pandemic emergency. A PHEIC is an international health alert and coordination mechanism; a pandemic requires widespread global community transmission, which Ebola does not currently have. WHO advised against border closures or travel bans.

Bundibugyo virus is one of six known species of Orthoebolaviruses (the family that causes Ebola disease). It was first identified in Uganda in 2007. It is significantly rarer than the Zaire strain, has a lethality rate of up to 50%, and — critically — has no approved vaccine or specific treatment. The Ervebo vaccine and the Inmazeb/Ebanga antibody treatments used in recent DRC outbreaks are effective only against the Zaire strain, not Bundibugyo.

The gold standard is RT-PCR (reverse transcription polymerase chain reaction), which detects Ebola viral RNA in blood — it becomes reliably positive from approximately day 3 of symptoms. Antigen-capture ELISA tests detect Ebola surface proteins and can be used in field settings without PCR equipment. IgM and IgG antibody tests detect the immune response and are used in contact tracing and survivor studies. All Ebola testing in the US is coordinated with the CDC; in the UK, samples go to the UKHSA Porton Down laboratory.

Ebola is NOT airborne and does not spread through casual contact such as sitting near someone on a plane. It spreads only through direct contact with the blood or body fluids (vomit, faeces, urine, saliva) of a person who is already showing symptoms. During the incubation period (up to 21 days before symptoms), an infected person is not infectious. The risk of transmission to a fellow passenger from an asymptomatic traveller is negligible.

The CDC, ECDC, and WHO all assess the current risk to the general public in the US and Europe as low. Ebola does not spread through the air and requires direct contact with body fluids of a symptomatic person. During the much larger 2014–2016 West Africa epidemic (nearly 30,000 cases), only a handful were exported to Europe — mostly repatriated healthcare workers. People who have not travelled to DRC or Uganda and have no contact with anyone from those countries face a negligible risk at this time.

Monitor yourself for symptoms — fever, headache, muscle pain, vomiting, diarrhoea — for 21 days after your return (the maximum incubation period). If you develop a fever within this window, do not go to a public emergency room — call your doctor or local health department first, disclose your travel history, and follow their instructions. In the US, call 911 and inform dispatchers of your travel history. In the UK, call 999 and tell the operator you have recently been to DRC or Uganda.

Three key reasons: First, the Bundibugyo strain has no approved vaccine, so the ring vaccination strategy that helped contain the 2018–2020 DRC Zaire outbreak cannot be used. Second, the outbreak started in Ituri Province — a remote, conflict-affected area with limited healthcare infrastructure and significant population movement across the DRC-Uganda border. Third, it has already spread to Kampala, a major city, within days of being confirmed, suggesting wider community transmission than the official case count reflects.

The key differences are transmission route and global spread potential. Ebola spreads only through direct contact with body fluids of a symptomatic person — it is not airborne. COVID-19 is highly airborne and spreads through respiratory particles in any enclosed space. Ebola has never caused sustained community transmission outside of Africa in any outbreak. COVID-19 spread to every country on Earth within weeks. The 2026 Ebola outbreak, while serious, has a fundamentally different spread profile to COVID-19.